CORC

在结果中检索

CORC

浏览/检索结果: 共48条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
A Novel Binary Jaya Optimization for Economic/Emission Unit Commitment 会议论文
里约, 2018
作者:  Y. Zhou;  Z. Yang;  Y. Guo;  Q. Niu;  H. Ma
收藏  |  浏览/下载：16/0  |  提交时间：2019/01/31
HER2 amplification is associated with higher tumor mutation burden in breast cancer 会议论文
作者:  Yin, Y.;  Li, W.;  Huang, X.;  Wu, H.;  Zhang, Y.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/04
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
A Phase IIIb Trial of Afatinib in EGFRm plus NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Risk Factors Affecting Prognosis in Metachronous Liver Metastases from WHO Classification G1 and G2 Gastroenteropancreatic Neuroendocrine Tumors after Initial R0 Surgical Resection 会议论文
作者:  Lyu, Y.;  Han, X.;  Xu, X.;  Ji, Y.;  Zhou, Y.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Hu, Y.;  Liu, Z.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib for treatment-naive advanced hepatocellular carcinoma (HCC) in Asian patients 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Exposure to PM2.5 Activates Hypothalamic-Pituitary-Adrenal Axis in Mouse Models and Humans 会议论文
作者:  Xu, Y.;  Chen, M.;  Zhou, J.;  Li, H.;  Zhang, X.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Liu, Z.;  Hu, Y.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC) 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace